SNSE — Sensei Biotherapeutics Balance Sheet
0.000.00%
- $10.69m
- -$29.81m
- 29
- 54
- 18
- 25
Annual balance sheet for Sensei Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 16.6 | 148 | 107 | 65.8 | 41.3 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 20.1 | 149 | 109 | 67.3 | 41.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.27 | 4.64 | 9.72 | 7.04 | 3.38 |
Other Long Term Assets | |||||
Total Assets | 21.4 | 153 | 118 | 74.4 | 45.4 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.83 | 4.89 | 9.07 | 5.64 | 5.45 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.54 | 6.71 | 15 | 9.48 | 6.97 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 15.9 | 147 | 103 | 64.9 | 38.4 |
Total Liabilities & Shareholders' Equity | 21.4 | 153 | 118 | 74.4 | 45.4 |
Total Common Shares Outstanding |